Tivantinib Decreases Hepatocyte Growth Factor-Induced BCRP Expression in Hepatocellular Carcinoma HepG2 Cells

Kobayashi, K; Higai, K; Mukozu, T; Matsui, D; Amanuma, M; Yoshimine, N; Ogino, Y; Matsui, T; Wakui, N; Shinohara, M; Momiyama, K; Daido, Y; Nagai, H; Igarashi, Y

BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2020; 43 (9): 1421

Abstract

Tivantinib, a mesenchymal epithelial transition factor (cMET) inhibitor, is a molecular targeting drug that kills hepatocellular carcinoma (HCC) cells......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索